| home | genetic laboratories | Health professionals | patients, public & policy | participants | about us | Contact Info | events & news |
|
Event - EuroGentest 3rd Scientific Symposium |
|
|
|
|
EuroGentest2 coordination team Leuven:
admin@eurogentest.org
International Scientific Symposium: Moving Next Generation Sequencing into Diagnostics
We would like to thank all speakers and participants for a very successful conference! It was filled with inspiring presentations and lively discussions. Also a big thank you to our colleagues in Prague for the warm welcome!
The presentations are available on this webpage (see right column). Please make sure you are registered on the website, and logged in to see the presentations. After registration we will grant you access (this can take a couple of days).
After the success of the joint EuroGentest/Techgene Scientific Symposia in Leuven, Belgium (February 2011) and Nijmegen, The Netherlands (January 2012), EuroGentest will organize a third edition in March 2013. This year, the meeting will be co-organized by APOGEE-Net/CanGènetest
and will take place in Prague (Czech Republic) in the OREA Hotel Pyramida 4*.
The symposium will be open to all interested i.e. not limited to EuroGentest partners.
There is NO FEE but registration is required!
EUROGENTEST-ONLY MEETINGS : Wednesday and Thursday March 6 and 7: if you are a EuroGentest participant you can log in and find more information here .
13.30-18.00: Session 1: Technological and quality issues of next generation sequencing
- Milan Macek Jr (CZE) and Gert Matthijs (BEL): Introduction and welcome
- Hans Scheffer (NED): Towards guidelines for diagnostic NGS
- Peter Robinson (GER): Building genomic databases
- Erika Souche (BEL): Quality control of NGS data processing
- Quality issues:
- Keynote speaker: Les Biesecker (US): "Hypothesis-Generating Research and Predictive Medicine: Opportunities and Challenges"
8.30-11.30: Session 2: Health technology assessment of next generation sequencing
- Jean Lachaine (CAN): Evaluating to cost-effectiveness of Next Generation Sequencing in clinical practice
- Elles Boon (NED): A national validation and implementation study for Non Invasive Trisomy Testing within the Netherlands
- Wolf Rogowski (GER):Points to consider for prioritizing genetic tests
- Aly Karsan (CAN): Development of next-generation sequencing assays for hereditary cancer testing
13.00-16.00: Session 3: Incidental findings in the clinic through the use of genome sequencing
- Leigh Jackson (U.K.): Incidental findings in research and the clinic: a systematic review, an exploratory study of clinical and public perspectives and initial results from NHS Research Ethics Committee member interviews
- Jan M Friedman (CAN): Incidental findings in clinical whole genomic sequencing
- Tessel Rigter (NED): Exploring needs for the informed consent procedure for genome sequencing in dagnostics
- Panel discussion (Incidental findings)
- Bartha Knoppers (CAN): International normative perspectives on the return of individual research and incidental findings in genomic biobanks. Research versus clinic?
Christian Netzer
Milan Macek
Hans Scheffer
Els Dequeker
Francois Rousseau
Pascal Borry
Martina Cornel
Heather Skirton
Helena Kaariainen
Ros Hastings
The symposium will take place in the historical city of Prague in the Czech Republic. The conference venue is the OREA Hotel Pyramida 4
*.
You can also book a room at the OREA Hotel Pyramida at special EuroGentest rates (click here).
!! Rates are valid untill January 30th 2013, so book your room as soon as possible !!
|
|
|
|
Copyright EuroGentest2 Coordination Action 2011 - EU Contract no.: FP7 - HEALTH-F4-2010-261469